Table 1.
Strain | mean life span ± SEM 20°C (days) | Median lifespan | 75th percentile 20°C (days) | 25th percentile 20°C (days) | p value against control | n | Trials |
---|---|---|---|---|---|---|---|
N2 | 20.44 ± 0.3 | 21 | 23 | 19 | - | 90/90 | 1 |
daf-2 (e1368) | 29.42 ± 0.3 | 31 | 31 | 29 | <.0001a | 91/91 | 1 |
daf-2 (e1370) | 39.39 ± 0.4 | 39 | 43 | 37 | <.0001a | 88/88 | 1 |
daf-16 (mgDf47) | 16.80 ± 0.3 | 17 | 19 | 15 | <.0001a | 50/50 | 1 |
daf-16 (mgDf47) ; daf-2 (e1370) | 20.01 ± 0.1 | 21 | 21 | 19 | <.0001b | 77/80 | 1 |
skn-1(zu67) | 15.60 ± 0.3 | 17 | 17 | 15 | <.0001a | 73/73 | 1 |
skn-1(zu129) | 17.67 ± 0.2 | 17 | 19 | 17 | <.0001a | 90/90 | 1 |
skn-1(zu135) | 17.70 ± 0.3 | 17 | 19 | 17 | <.0001a | 57/57 | 1 |
daf-2 (e1368); skn-1(zu67) | 22.63 ± 0.5 | 23 | 25 | 21 | <.0001c | 60/60 | 1 |
daf-2 (e1368); skn-1(zu129) | 22.25 ± 1.1 | 19 | 29 | 15 | <.0001c | 58/60 | 1 |
daf-2 (e1368); skn-1(zu135) | 19.83 ± 0.6 | 19 | 23 | 17 | <.0001c | 58/59 | 1 |
daf-2 (e1370); skn-1(zu67) | 38.60 ± 1.0 | 41 | 43 | 35 | .0740b | 60/60 | 1 |
daf-2 (e1370); skn-1(zu129) | 27.64 ± 0.7 | 27 | 31 | 23 | <.0001b | 62/62 | 1 |
daf-2 (e1370); skn-1(zu135) | 33.16 ± 0.6 | 39 | 43 | 33 | .6016b | 25/25 | 1 |
rrf-3(pk1426);control(RNAi) | 19.53 ± 0.5 | 19 | 24 | 17 | - | 57/60 | 1 |
rrf-3(pk1426);skn-1(RNAi) | 20.43 ± 0.6 | 21 | 24 | 15 | .1531g | 60/60 | 1 |
rrf-3(pk1426);skn-1a/c(RNAi) | 20.27 ± 0.6 | 21 | 24 | 15 | .2313g | 59/60 | 1 |
rrf-3(pk1426);daf-2(e1368) control(RNAi) | 38.62 ± 1.3 | 40 | 44 | 34 | <.0001g | 52/55 | 1 |
rrf-3(pk1426); daf-2(e1368) skn-1(RNAi) | 25.83 ± 1.3 | 21 | 36 | 17 | <.0001d | 56/56 | 1 |
rrf-3(pk1426); daf-2(e1368) skn-1a/c (RNAi) | 26.32 ± 1.3 | 24 | 36 | 19 | <.0001d | 57/58 | 1 |
N2 [rol-6]; control(RNAi) | 20.1 ± 0.3 | 20 | 22 | 18 | 84/84 | 1 | |
skn-1(zu67); control(RNAi) | 14.6 ± 0.4 | 14 | 16 | 12 | <.0001e | 87/90 | 1 |
N2 [rol-6]; cyc-1(RNAi) | 42.1 ± 0.9 | 42 | 45 | 40 | <.0001e | 32/34 | 1 |
skn-1(zu67); cyc-1(RNAi) | 41.9 ± 1.2 | 45 | 47 | 38 | .5594f | 38/38 | 1 |
N2 [rol-6]; cco-1(RNAi) | 31.52 ± 0.5 | 32 | 34 | 30 | <.0001e | 67/69 | 1 |
skn-1(zu67); cco-1(RNAi) | 35.13 ± 0.5 | 36 | 38 | 34 | <.0001f | 46/46 | 1 |
Strain | mean adult life span ± SEM 25°C (days) | Median lifespan | 75th Percentile 25°C (days) | 25th percentile 25°C (days) | p value against Control | n | No. Exp |
rrf-3(pk1426); control(RNAi) | 12.90 ± 0.4 | 13 | 15 | 11 | - | 99/100 | 2 |
daf-16(mgDf47) | 11.04 ± 0.2 | 11 | 13 | 9 | <.0001g | 138/138 | 3 |
rrf-3(pk1426); akt1; akt-2(RNAi) | 22.50 ± 0.7 | 22 | 28 | 17 | <.0001g | 120/138 | 2 |
daf-16(mgdf47); rrf-3(pk1426); akt1; akt-2(RNAi) | 11.03 ± 0.3 | 11 | 13 | 10 | <.0001h | 123/123 | 3 |
rrf-3(pk1426);skn-1(zu67); control(RNAi) | 7.20 ± 0.2 | 7 | 8 | 6 | <.0001g | 106/106 | 2 |
rrf-3(pk1426);skn-1(zu129);control(RNAi) | 9.30 ± 0.4 | 8 | 12 | 7 | <.0001g | 100/100 | 2 |
rrf-3(pk1426);skn-1(zu135);control(RNAi) | 12.00 ± 0.3 | 12 | 15 | 9 | 0.1012g | 150/150 | 3 |
rrf-3(pk1426);skn-1(zu67); akt-1; akt-2(RNAi) | 11.60 ± 0.6 | 11 | 17 | 6 | <.0001h | 104/104 | 2 |
rrf-3(pk1426);skn-1(zu129); akt-1; akt-2(RNAi) | 20.40 ± 1.0 | 21 | 28 | 12 | 0.9400h | 101/104 | 2 |
rrf-3(pk1426);skn-1(zu135); akt-1; akt-2(RNAi) | 17.69 ± 0.6 | 17 | 22 | 13 | <.0001h | 110/110 | 3 |
N2; control(RNAi) | 13.8 ± 0.3 | 14 | 16 | 12 | - | 110/114 | 2 |
N2; sgk-1(RNAi) | 22.6 ± 0.4 | 23 | 25 | 21 | <.0001e | 110/395 | 2 |
skn-1(zu67); sgk-1(RNAi) | 8.2 ± 0.2 | 8 | 10 | 7 | <.0001i | 128/128 | 2 |
skn-1(zu129); sgk-1(RNAi) | 9.1 ± 0.2 | 8 | 11 | 7 | <.0001i | 185/186 | 2 |
Corresponds to the data in Figure 4C–H. SEM: standard error of the mean. 75th and 25th percentiles refer to the day at which 75% or 25% of the population is dead. n represents total number of animals dying of old age vs those in total experiment (combined between trials where appropriate). In the case of sgk-1(RNAi) the majority of exclusions are due to Egl/bag of worms phenotypes. p values were calculated as follows:
N2,
daf-2(e1370),
daf-2(e1368),
rrf-3(pk1426);daf-2(e1368) control(RNAi),
N2 control(RNAi),
N2 with corresponding RNAi,
rrf-3(pk1426) control(RNAi),
rrf-3(pk1426) akt-1;akt-2(RNAi),
sgk-1(RNAi). Individual experiments, an additional analysis of daf-2(e1368) and daf-2(e1370), and other supporting data are in Table S5.